Natural Product (NP) Details
| General Information of the NP (ID: NP7659) | |||||
|---|---|---|---|---|---|
| Name |
Bovine lactoferrin
|
||||
| Species Origin | Milk vetch dwarf China alphasatellite ... | Click to Show/Hide | |||
| Milk vetch dwarf China alphasatellite | |||||
| Disease | Diarrhea [ICD-11: ME05] | Phase 2 | [1] | ||
| ADMET Property |
Absporption
Caco-2 Permeability
-4.968
MDCK Permeability
-4.646
PAMPA
+++
HIA
- - -
Distribution
VDss
-0.102
PPB
90.5%
BBB
+++
Metabolism
CYP1A2 inhibitor
- - -
CYP1A2 substrate
- - -
CYP2C19 inhibitor
- - -
CYP2C19 substrate
- - -
CYP2C9 inhibitor
- - -
CYP2C9 substrate
- - -
CYP2D6 inhibitor
- - -
CYP2D6 substrate
- - -
CYP3A4 inhibitor
+++
CYP3A4 substrate
+++
CYP2B6 inhibitor
- - -
CYP2B6 substrate
- - -
CYP2C8 inhibitor
- - -
HLM Stability
- - -
Excretion
CLplasma
6.011
T1/2
0.813
Toxicity
DILI
+++
Rat Oral Acute Toxicity
-
FDAMDD
++
Respiratory
++
Human Hepatotoxicity
++
Ototoxicity
++
Drug-induced Nephrotoxicity
+++
Drug-induced Neurotoxicity
+++
Hematotoxicity
-
Genotoxicity
+++
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| Penicillin G | Syphilis | Click to Show/Hide the Molecular Data of This Drug | ||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| In-vivo Model | Nineteen late-lactating cows had all 4 mammary quarters individually inoculated (185 cfu) through the teat cistern with the PG-resistant Staph. Aureus SHY97-4320. | |||||
| Experimental
Result(s) |
BLF added to PG is an effective combination (i.e., 3- to 5-times higher cure rate) for the treatment of stable Staph. aureu infections highly resistant to beta-lactam antibiotics. | |||||